How inhibitory signals from the cerebellum help control movement
Functional roles of inhibitory cerebellar outputs
This project looks at how certain inhibitory brain signals from the cerebellum help the nervous system learn to slow and stop reaches accurately, which could help people with cerebellar movement problems.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11181570 on NIH RePORTER |
What this research studies
From a patient perspective, the team uses mice trained to reach for targets while measuring limb movement precisely. They turn specific cerebellar circuits on or off in real time with a closed-loop setup to see how inhibitory output neurons change so-called 'teaching' signals and adjust braking during reaches. The work focuses on cell types in the interposed nucleus and their influence on Purkinje cells and the inferior olive to understand how the brain recalibrates when reaches miss the target. Results aim to reveal circuit mechanisms that underlie dysmetria and other cerebellar movement errors.
Who could benefit from this research
Good fit: People with cerebellar damage or cerebellar ataxia who have trouble with coordination and inaccurate reaches would be the most relevant patient group for eventual translation of these findings.
Not a fit: Patients whose symptoms arise from non-cerebellar causes or primarily sensory problems are unlikely to benefit directly from this line of basic-circuit research in the near term.
Why it matters
Potential benefit: If successful, this work could point to specific brain circuits or cell types that become targets for future treatments to reduce imprecise reaching and other cerebellar movement problems.
How similar studies have performed: Prior mouse circuit-manipulation studies have already shown that interposed nucleus activity affects reach kinematics, but translating these mechanistic findings into human therapies remains unproven.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Person, Abigail L — University of Colorado Denver
- Study coordinator: Person, Abigail L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.